Embolization Market, By Product Type Particles, Liquid Embolic, Plugs, Coils), By Indication (Hemorrhage/Bleeding, Benign Prostatic Hyperplasia, Uterine Fibroid, Tumor, Malformation (AVM, AVF), Venous embolization, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Jun 2024

Code : CMI4473

Pages :410

Formats :

Excel and PDF

Industry : Medical Devices

Regional Analysis

Embolization Market Regional Insights

To learn more about this report, request sample copy

North America has established itself as the dominant region in the global embolization market with estimated market share of 39.3% in 2024 due to well-established healthcare and research infrastructure. Major pharmaceutical and biotechnology companies have their headquarters in the U.S. and Canada that provides them an edge in R&D for new embolization. Furthermore, the presence of top medical devices players engaged in neurobiology research and development can drive the regional growth market. Support from government bodies in the form of grants and funding for neuroscience projects has also propelled the market growth. Several universities and academic institutions in the U.S. and Canada are engaged in collaborative research with industry players to discover novel biomarkers.

Asia Pacific is poised to be the fastest growing region over the forecast period due to improving healthcare infrastructure and increasing expenditure on neurology care. Rapid economic development of countries such as China and India have increased access to advanced healthcare facilities. Rising focus on early disease diagnosis and availability of low-cost skilled labor for manufacturing are attracting biopharmaceutical players to establish production and R&D hubs in Asia Pacific. This has augmented investments in the regional embolization industry.